Cargando...
Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1
BACKGROUND: Heart pathological hypertrophy has been recognized as a predisposing risk factor for heart failure and arrhythmia. DUSP (dual‐specificity phosphatase) 26 is a member of the DUSP family of proteins, which has a significant effect on nonalcoholic fatty liver disease, neuroblastoma, glioma,...
Gardado en:
| Publicado en: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955340/ https://ncbi.nlm.nih.gov/pubmed/33522247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.014311 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|